Insomnia - Drug Pipeline Landscape, 2022

Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily life.

Insomnia has one of the most active pipelines with more than 200 drugs under development. Global Insight Services have recently published a report on Insomnia Pipeline, the only comprehensive source of information you need to understand developments related to Alzheimer's pipeline. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.

To know more about Alzheimer's pipeline, visit - https://www.globalinsightservices.com/reports/insomnia-drug-pipeline-landscape-2022/

Insomnia - Drug Pipeline Landscape, 2022 report will provide you with:

• Assessment by Stage of Development
• Assessment by Companies
• Assessment by Target
• Assessment by Mechanism of Action
• Assessment by Molecule Type
• Assessment by Route of Administration
• Comprehensive drug profiles including development stage, molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations
• Details of key deals, clinical trials, and upcoming milestones

Key Players -
• Bod Australia
• Cennerv Pharma (S) Pte Ltd
• Closed Loop Medicine Ltd
• Defined Research
• Eisai Co., Ltd
• EMS
• Evotec International GmbH
• Idorsia Pharmaceuticals Ltd.
• Imbrium Therapeutics
• Janssen Research & Development, LLC
• Sequential Medicine Ltd
• Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
• Sunshine Lake Pharma Co., Ltd.
• Taisho Pharmaceutical Co., Ltd.

Get a free sample copy of this Report - https://www.globalinsightservices.com/request-sample/GIS31016

Reasons to buy this report:

- Find and recognize significant therapeutics under development.
- Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
- Plan collaborations with various industry partners that have role in some or the other stage of drug development process such as contract manufacturing, co-development, contract research organization and commercialization etc.
- Create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.

Buy this report - https://www.globalinsightservices.com/checkout/single_user/GIS31016

Report Segmentation -
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.